• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Barriers and perceived usefulness of an ECHO intervention for office-based buprenorphine treatment for opioid use disorder in North Carolina: A qualitative study.北卡罗来纳州基于诊所用丁丙诺啡治疗阿片类药物使用障碍的 ECHO 干预措施的障碍和感知有用性:一项定性研究。
Subst Abus. 2021;42(1):54-64. doi: 10.1080/08897077.2019.1694617. Epub 2019 Dec 6.
2
Barriers and facilitators to nurse practitioner buprenorphine prescribing for opioid use disorder in primary care settings.在初级保健环境中,护士从业者开具丁丙诺啡治疗阿片类药物使用障碍的障碍和促进因素。
J Am Assoc Nurse Pract. 2023 Feb 1;35(2):112-121. doi: 10.1097/JXX.0000000000000811.
3
Association of MOUD ECHO Participation on Expansion of Buprenorphine Prescribing in Rural Primary Care.农村基层医疗中 MOUD ECHO 参与度对丁丙诺啡处方扩展的影响。
Subst Abus. 2023 Oct;44(4):282-291. doi: 10.1177/08897077231198971. Epub 2023 Oct 30.
4
Expanding treatment for opioid use disorder in publicly funded primary care clinics: Exploratory evaluation of the NYC health + hospitals buprenorphine ECHO program.在公共资助的基层医疗诊所中扩大阿片类药物使用障碍的治疗:对纽约市卫生+医院丁丙诺啡 ECHO 项目的探索性评估。
J Subst Abuse Treat. 2019 Nov;106:1-3. doi: 10.1016/j.jsat.2019.08.003. Epub 2019 Aug 9.
5
Rural access to MAT in Pennsylvania (RAMP): a hybrid implementation study protocol for medication assisted treatment adoption among rural primary care providers.宾夕法尼亚州农村获取 MAT(RAMP):一项混合实施研究方案,旨在促进农村初级保健提供者采用药物辅助治疗。
Addict Sci Clin Pract. 2019 Aug 1;14(1):25. doi: 10.1186/s13722-019-0154-4.
6
Use of Project ECHO to promote evidence based care for justice involved adults with opioid use disorder.利用 ECHO 项目促进基于证据的护理,以满足涉及阿片类药物使用障碍的成年罪犯的需求。
Subst Abus. 2022;43(1):336-343. doi: 10.1080/08897077.2021.1941518. Epub 2021 Jul 20.
7
Strategies to recruit rural primary care providers to implement a medication for opioid use disorder (MOUD) focused integrated care model.招募农村初级保健提供者以实施专注于阿片类药物使用障碍药物治疗(MOUD)的综合护理模式的策略。
Implement Res Pract. 2023 Feb 19;4:26334895231152808. doi: 10.1177/26334895231152808. eCollection 2023 Jan-Dec.
8
Feasibility and acceptability of an online ECHO intervention to expand access to medications for treatment of opioid use disorder, psychosocial treatments and supports.在线 ECHO 干预扩大阿片类药物使用障碍、心理社会治疗和支持的药物治疗的可行性和可接受性。
Subst Abus. 2021;42(4):610-617. doi: 10.1080/08897077.2020.1806184. Epub 2020 Aug 19.
9
Advancing pharmacological treatments for opioid use disorder (ADaPT-OUD): protocol for testing a novel strategy to improve implementation of medication-assisted treatment for veterans with opioid use disorders in low-performing facilities.推进阿片类药物使用障碍的药理学治疗(ADaPT-OUD):在表现不佳的机构中为患有阿片类药物使用障碍的退伍军人改善药物辅助治疗实施的新策略的测试方案。
Addict Sci Clin Pract. 2018 Dec 13;13(1):25. doi: 10.1186/s13722-018-0127-z.
10
The Role of Primary Care in Improving Access to Medication-Assisted Treatment for Rural Medicaid Enrollees with Opioid Use Disorder.初级保健在改善农村医疗补助计划参保者阿片类药物使用障碍患者获得药物辅助治疗方面的作用。
J Gen Intern Med. 2019 Jun;34(6):936-943. doi: 10.1007/s11606-019-04943-6. Epub 2019 Mar 18.

引用本文的文献

1
Creation of the ECHO Idaho Podcast: Tutorial and Pilot Assessment.爱达荷州ECHO播客的创建:教程与试点评估
JMIR Med Educ. 2025 Mar 21;11:e55313. doi: 10.2196/55313.
2
The perpetual evidence-practice gap: addressing ongoing barriers to chronic pain management in primary care in three steps.长期存在的证据与实践差距:分三步解决初级保健中慢性疼痛管理的持续障碍。
Front Pain Res (Lausanne). 2024 Oct 8;5:1376462. doi: 10.3389/fpain.2024.1376462. eCollection 2024.
3
"Moving beyond silos": focus groups to understand the impact of an adapted project ECHO model for a multidisciplinary statewide forum of substance use disorder care leaders manuscript authors.“超越孤岛”:焦点小组以了解适应性项目ECHO模型对物质使用障碍护理领导者多学科全州论坛的影响 稿件作者
Addict Sci Clin Pract. 2024 Aug 8;19(1):58. doi: 10.1186/s13722-024-00485-3.
4
Trends in the Prescribing of Buprenorphine for Opioid Use Disorder, 2019-2023.2019 - 2023年用于阿片类物质使用障碍的丁丙诺啡处方趋势
Mayo Clin Proc Innov Qual Outcomes. 2024 May 24;8(3):308-320. doi: 10.1016/j.mayocpiqo.2024.04.004. eCollection 2024 Jun.
5
Key conditions for the successful implementation of evidence-based practice in concurrent disorder nursing care with the ECHO® model: Insights from a mixed-methods study.采用ECHO®模式在并发疾病护理中成功实施循证实践的关键条件:一项混合方法研究的见解
Int J Nurs Stud Adv. 2023 Sep 7;5:100153. doi: 10.1016/j.ijnsa.2023.100153. eCollection 2023 Dec.
6
Formative Evaluation and Adaptation of a Hypertension Extension for Community Health Outcomes Program for Healthcare Workers within the Federal Capital Territory, Nigeria.尼日利亚联邦首都特区医疗工作者社区卫生成果计划高血压拓展模块的形成性评价与改编。
Glob Heart. 2023 Nov 27;18(1):64. doi: 10.5334/gh.1277. eCollection 2023.
7
Will the End of the X-Waiver Expand Access to Buprenorphine Treatment? Achieving the Full Potential of the 2023 Consolidated Appropriations Act.X 弃权的终结是否会扩大丁丙诺啡治疗的可及性?实现 2023 年综合拨款法案的全部潜力。
Subst Abus. 2023 Jul;44(3):108-111. doi: 10.1177/08897077231186212. Epub 2023 Sep 7.
8
Exploring the Association of State Policies and the Trajectories of Buprenorphine Prescriber Patient Caseloads.探讨州政策与丁丙诺啡类药物处方患者病例数轨迹之间的关联。
Subst Abus. 2023 Jul;44(3):136-145. doi: 10.1177/08897077231179824. Epub 2023 Jul 4.
9
Evaluation of the New England Office Based Addiction Treatment ECHO: A Tool for Strengthening the Addiction Workforce.评估新英格兰基于办公室的成瘾治疗 ECHO:一个加强成瘾治疗人员队伍的工具。
Subst Abus. 2023 Jul;44(3):164-176. doi: 10.1177/08897077231179601. Epub 2023 Jun 7.
10
Augmenting project ECHO for opioid use disorder with data-informed quality improvement.利用数据驱动的质量改进来增强 ECHO 项目治疗阿片类药物使用障碍。
Addict Sci Clin Pract. 2023 Apr 28;18(1):24. doi: 10.1186/s13722-023-00381-2.

本文引用的文献

1
Prescribing Practices of Rural Physicians Waivered to Prescribe Buprenorphine.农村医生开具丁丙诺啡处方的规定豁免。
Am J Prev Med. 2018 Jun;54(6 Suppl 3):S208-S214. doi: 10.1016/j.amepre.2018.02.006.
2
Adapting the Consolidated Framework for Implementation Research to Create Organizational Readiness and Implementation Tools for Project ECHO.调整实施研究综合框架,为ECHO项目创建组织准备情况和实施工具。
J Contin Educ Health Prof. 2018 Spring;38(2):145-151. doi: 10.1097/CEH.0000000000000195.
3
Mortality in the United States, 2016.美国2016年的死亡率
NCHS Data Brief. 2017 Dec(293):1-8.
4
Project ECHO Telementoring Intervention for Managing Chronic Pain in Primary Care: Insights from a Qualitative Study.ECHO 项目远程指导干预在初级保健中管理慢性疼痛的效果:一项定性研究的见解。
Pain Med. 2018 Jun 1;19(6):1140-1146. doi: 10.1093/pm/pnx233.
5
Why aren't physicians prescribing more buprenorphine?为什么医生没有开出更多的丁丙诺啡?
J Subst Abuse Treat. 2017 Jul;78:1-7. doi: 10.1016/j.jsat.2017.04.005. Epub 2017 Apr 12.
6
Buprenorphine prescribing practice trends and attitudes among New York providers.纽约医疗服务提供者丁丙诺啡的处方开具实践趋势及态度
J Subst Abuse Treat. 2017 Mar;74:1-6. doi: 10.1016/j.jsat.2016.10.005. Epub 2016 Oct 29.
7
Physician Capacity to Treat Opioid Use Disorder With Buprenorphine-Assisted Treatment.医生使用丁丙诺啡辅助治疗阿片类物质使用障碍的能力。
JAMA. 2016 Sep 20;316(11):1211-1212. doi: 10.1001/jama.2016.10542.
8
The Impact of Project ECHO on Participant and Patient Outcomes: A Systematic Review.“拓展社区医疗成果”(ECHO)项目对参与者和患者治疗结果的影响:一项系统综述
Acad Med. 2016 Oct;91(10):1439-1461. doi: 10.1097/ACM.0000000000001328.
9
National and State Treatment Need and Capacity for Opioid Agonist Medication-Assisted Treatment.国家和州对阿片类激动剂药物辅助治疗的需求及能力
Am J Public Health. 2015 Aug;105(8):e55-63. doi: 10.2105/AJPH.2015.302664. Epub 2015 Jun 11.
10
Geographic and specialty distribution of US physicians trained to treat opioid use disorder.接受过治疗阿片类药物使用障碍培训的美国医生的地理分布和专业分布。
Ann Fam Med. 2015 Jan-Feb;13(1):23-6. doi: 10.1370/afm.1735.

北卡罗来纳州基于诊所用丁丙诺啡治疗阿片类药物使用障碍的 ECHO 干预措施的障碍和感知有用性:一项定性研究。

Barriers and perceived usefulness of an ECHO intervention for office-based buprenorphine treatment for opioid use disorder in North Carolina: A qualitative study.

机构信息

University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA.

出版信息

Subst Abus. 2021;42(1):54-64. doi: 10.1080/08897077.2019.1694617. Epub 2019 Dec 6.

DOI:10.1080/08897077.2019.1694617
PMID:31809679
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7274853/
Abstract

Medication treatment for opioid use disorder (M-OUD) is underutilized, despite research demonstrating its effectiveness in treating opioid use disorder (OUD). The UNC Extension for Community Healthcare Outcomes for Rural Primary Care Medication Assisted Treatment (UNC ECHO for MAT) project was designed to evaluate interventions for reducing barriers to delivery of M-OUD by rural primary care providers in North Carolina. A key element was tele-conferenced sessions based on the University of New Mexico Project ECHO model, comprised of case discussions and didactic presentations using a "hub and spoke" model, with expert team members at the hub site and community-based providers participating from their offices (i.e., spoke sites). Although federal funders have promoted use of the model, barriers for providers to participate in ECHO sessions are not well documented. : UNC ECHO for MAT included ECHO sessions, provider-to-provider consultations, and practice coaching. We conducted 20 semi-structured interviews to assess perceived usefulness of the UNC ECHO for MAT intervention, barriers to participation in the intervention, and persistent barriers to prescribing M-OUD. : Participants were generally satisfied with ECHO sessions and provider-to-provider consultations; however, perceived value of practice support was less clear. Primary barriers to participating in ECHO sessions were timing and length of sessions. Participants recommended recording ECHO sessions for viewing later, and some thought incentives for either the practice or provider could facilitate participation. Providers who had participated in ECHO sessions valued the expertise on the expert team; the team's ability to develop a supportive, collegial environment; and the value of a community of providers interested in learning from each other, particularly through case discussions. : Despite the perceived value of ECHO, barriers may prevent consistent participation. Also, barriers to M-OUD delivery remain, including some that ECHO alone cannot address, such as Medicaid and private-insurer policies and availability of psychosocial resources.

摘要

尽管有研究表明,药物治疗阿片类药物使用障碍(M-OUD)在治疗阿片类药物使用障碍(OUD)方面非常有效,但这种治疗方法的应用仍不充分。UNC 社区医疗成果农村初级保健药物辅助治疗(UNC ECHO for MAT)项目旨在评估干预措施,以减少北卡罗来纳州农村初级保健提供者提供 M-OUD 时遇到的障碍。该项目的一个关键要素是基于新墨西哥大学 ECHO 项目模型的远程会议,会议由案例讨论和使用“中心辐射”模式的专题演讲组成,专家团队成员在中心站点,社区医疗机构的参与者则在他们的办公室(即辐射站点)参与。尽管联邦资助者已经提倡使用这种模式,但提供者参与 ECHO 会议的障碍并没有得到很好的记录。

UNC ECHO for MAT 包括 ECHO 会议、提供者间咨询和实践指导。我们进行了 20 次半结构化访谈,以评估 UNC ECHO for MAT 干预措施的有用性、参与该干预措施的障碍以及持续存在的 M-OUD 处方障碍。

参与者普遍对 ECHO 会议和提供者间咨询感到满意;然而,实践支持的价值则不太明确。参与 ECHO 会议的主要障碍是会议的时间和长度。参与者建议录制 ECHO 会议以供日后观看,一些人认为对实践或提供者的激励措施可以促进参与。参加过 ECHO 会议的提供者非常重视专家团队的专业知识;团队营造支持性、合作性环境的能力;以及对有兴趣相互学习的提供者社区的重视,特别是通过案例讨论。

尽管 ECHO 被认为具有价值,但障碍可能会阻止人们持续参与。此外,M-OUD 提供方面仍然存在障碍,其中一些障碍仅凭 ECHO 无法解决,例如医疗补助和私人保险公司的政策以及心理社会资源的可用性。